Michael R Blackburn and colleagues showed that ADORA2B antagonism could significantly downregulate proinflammatory cytokines and chemokines and alleviate lung fibrosis, suggesting that ADORA2B signaling plays a central part in pulmonary injury and fibrosis in vivo [19]. The gene discussed is ADORA2B; the disease is pulmonary fibrosis.